CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 40 enrolled
Drug / intervention
Triamcinolone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00658736
NCT00658736Phase 3Completed
CompareCT.gov

A Randomized, Triple-Blinded Study of Endoscopic Ultrasound Guided Celiac Plexus Blockade (EUS-CPB) With Bupivicaine and Triamcinolone vs. Bupivicaine Alone for the Treatment of Pain in Chronic Pancreatitis

The Cleveland Clinic·interventional·Posted Apr 15, 2008·Updated Jun 14, 2017

In Brief

A Phase 3 clinical trial evaluating Triamcinolone and Bupivicaine alone for Chronic Pancreatitis. Completed, enrolled 40 participants across 1 site.

Detailed Summary

This is a triple-blind, parallel group, randomized controlled trial to assess the benefit of triamcinolone injection as a therapeutic measure for control of chronic pancreatitis pain. The treatment group will undergo EUS-CPB with bupivicaine plus triamcinolone ("therapeutic block"). There control group will undergo EUS-CPB with bupivicaine alone ("diagnostic block").

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pancreatitis
CountriesUnited States
CollaboratorsAmerican Society for Gastrointestinal Endoscopy, TAP Pharmaceutical Products Inc.

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 15, 2008
Enrollment StartMar 1, 2008
Primary CompletionJan 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 18.2 years ago

Interventions

Triamcinolonedrug

Injection of bupivacaine and triamcinolone

Bupivicaine alonedrug

Injection of bupivacaine